Literature DB >> 24533386

Comparison between perioperative treatment with calcium and with calcium and vitamin d in prevention of post thyroidectomy hypocalcemia.

Sanjana Vijay Nemade1, Vidya Vasant Rokade2, Netra Aniruddha Pathak2, Shannu Sushil Tiwari2, Sayali Jayant Sonkhedkar2.   

Abstract

Even though thyroid surgery is quite safe, mechanical damage, devascularization or inadvertent removal of the parathyroid glands are possible. Though postoperative mortality is extremely low, post thyroidectomy hypocalcemia is one of the most common and potentially life-threatening complication following thyroid surgery. The clinical manifestation varies from minimal twitching to life threatening tetany and can prolong the hospital stay. The purpose of this study is to evaluate the clinical usefulness of routine oral calcium with Vitamin D supplements in reducing the incidence and severity of hypocalcemia after total thyroidectomy. This safe and cost effective therapy may prevent the threatening complications like tetany and reduce the hospital stay.

Entities:  

Keywords:  Calcium; Hypocalcemia; Total thyroidectomy; Vitamin D

Year:  2012        PMID: 24533386      PMCID: PMC3918272          DOI: 10.1007/s12070-011-0430-4

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  17 in total

1.  Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy.

Authors:  Jong-Lyel Roh; Chan Il Park
Journal:  Am J Surg       Date:  2006-11       Impact factor: 2.565

2.  High-calcium mineral water as a calcium supplementing measure for post-thyroidectomy hypocalcemia.

Authors:  V Coiro; G Zanardi; G Saccani Jotti; P Rubino; G Manfredi; P Chiodera
Journal:  Minerva Endocrinol       Date:  2008-03       Impact factor: 2.184

3.  "Same-day" thyroid surgery: an analysis of safety, cost savings, and outcome.

Authors:  C R McHenry
Journal:  Am Surg       Date:  1997-07       Impact factor: 0.688

Review 4.  Hypocalcemia following thyroid surgery: incidence and prediction of outcome.

Authors:  F Pattou; F Combemale; S Fabre; B Carnaille; M Decoulx; J L Wemeau; A Racadot; C Proye
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

5.  [Complications in thyroid surgery: symptomatic post-operative hypoparathyroidism incidence, surgical technique, and treatment].

Authors:  Carmelo Sciumè; Girolamo Geraci; Franco Pisello; Tiziana Facella; Francesco Li Volsi; Antonella Licata; Giuseppe Modica
Journal:  Ann Ital Chir       Date:  2006 Mar-Apr       Impact factor: 0.766

6.  Oral calcium supplements to enhance early hospital discharge after bilateral surgical treatment of the thyroid gland or exploration of the parathyroid glands.

Authors:  F D Moore
Journal:  J Am Coll Surg       Date:  1994-01       Impact factor: 6.113

7.  Risk factors for postthyroidectomy hypocalcemia.

Authors:  C R McHenry; T Speroff; D Wentworth; T Murphy
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

8.  Bioavailability of calcium supplements and the effect of Vitamin D: comparisons between milk, calcium carbonate, and calcium carbonate plus vitamin D.

Authors:  L Mortensen; P Charles
Journal:  Am J Clin Nutr       Date:  1996-03       Impact factor: 7.045

9.  Vitamin D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine.

Authors:  R H Wasserman; C A Smith; M E Brindak; N De Talamoni; C S Fullmer; J T Penniston; R Kumar
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

10.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line.

Authors:  R J Wood; L Tchack; S Taparia
Journal:  BMC Physiol       Date:  2001-08-17
View more
  1 in total

1.  Outcome of parathyroid function after total thyroidectomy when calcium supplementation is administered routinely versus exclusively to symptomatic patients: A prospective randomized clinical trial.

Authors:  Zhe Li; Yuan Fei; Zhihui Li; Tao Wei; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2021-11-08       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.